Hepatitis Monthly

Published by: Kowsar

Comparison of the Prevalence and Risk Factors of Hepatitis A in 10 to 18-Year-Old Adolescents of Sixteen Iranian Provinces: The CASPIAN-III Study

Nasser Mostafavi 1 , Roya Kelishadi 1 , Elham Kazemi 2 , Behrooz Ataei 3 , Majid Yaran 4 , Mohammad Esmaeil Motlagh 5 , Mostafa Qorbani 6 , 7 , Ramin Heshmat 7 , Mohamad Hasan Tajadini 8 and Shervin Ghaffari Hoseini 2 , *
Authors Information
1 Pediatrics Department, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, IR Iran
2 Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran
3 Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran
4 Acquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran
5 Pediatrics Department, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
6 Department of Community Medicine, School of Medicine, Alborz University of Medical Sciences, Karaj, IR Iran
7 Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, IR Iran
8 Applied Physiology Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran
Article information
  • Hepatitis Monthly: September 2016, 16 (9); e36437
  • Published Online: August 17, 2016
  • Article Type: Research Article
  • Received: January 18, 2016
  • Revised: May 4, 2016
  • Accepted: August 10, 2016
  • DOI: 10.5812/hepatmon.36437

To Cite: Mostafavi N, Kelishadi R, Kazemi E, Ataei B, Yaran M, et al. Comparison of the Prevalence and Risk Factors of Hepatitis A in 10 to 18-Year-Old Adolescents of Sixteen Iranian Provinces: The CASPIAN-III Study, Hepat Mon. 2016 ;16(9):e36437. doi: 10.5812/hepatmon.36437.

Abstract
Copyright: Copyright © 2016, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Saberifiroozi M. Hepatitis A virus infection: Is it an important hazard to public health?: hazards of HAV for public health. Hepat Mon. 2011; 11(4): 235-7[PubMed]
  • 2. WHO position paper on hepatitis A vaccines - June 2012. Wkly Epidemiol Rec. 2012; 87(28/29): 261-76[PubMed]
  • 3. Hoseini SG, Kelishadi R, Ataei B, Yaran M, Motlagh ME, Ardalan G, et al. Seroprevalence of hepatitis A in Iranian adolescents: is it time to introduce a vaccine? Epidemiol Infect. 2016; 144(2): 291-6[DOI][PubMed]
  • 4. Farajzadegan Z, Hoseini SG, Kelishadi R, Jamshidi F, Nokhodian Z, Noori R, et al. Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran. J Res Med Sci. 2014; 19-63[PubMed]
  • 5. Merat S, Rezvan H, Nouraie M, Abolghasemi H, Jamali R, Amini-Kafiabad S, et al. Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study. Arch Iran Med. 2010; 13(2): 99-104[PubMed]
  • 6. Karimi A, Imani-Rastabi R, Moezzi M, Moradi MT. Hepatitis a seroprevalence and associated risk factors: A community-based cross-sectional study in shahrekord, iran. Arch Clin Infect Dis. 2016; 11(1)
  • 7. Kazemi SA, Mahram M, Koosha A, Amirmoghaddami HR. Seroprevalence of hepatitis a in 7-10 year-old children. Iran J Pediatr. 2007; 17(1): 47-51
  • 8. Asaei S, Ziyaeyan M, Moeini M, Jamalidoust M, Behzadi MA. Seroprevalence of Hepatitis A and E Virus Infections Among Healthy Population in Shiraz, Southern Iran. Jundishapur J Microbiol. 2015; 8(7): 19311[DOI][PubMed]
  • 9. Taghavi SA, Hosseini Asl MK, Talebzadeh M, Eshraghian A. Seroprevalence study of hepatitis A virus in Fars province, southern Iran. Hepat Mon. 2011; 11(4): 285-8[PubMed]
  • 10. Rafeey M, Shoaran M. Prevalence and risk factors of hepatitis a in children in tabriz, iran. J Anal Res Clin Med. 2014; 2(4): 183-6
  • 11. Khashayar P, Heshmat R, Qorbani M, Motlagh ME, Aminaee T, Ardalan G, et al. Metabolic Syndrome and Cardiovascular Risk Factors in a National Sample of Adolescent Population in the Middle East and North Africa: The CASPIAN III Study. Int J Endocrinol. 2013; 2013: 702095[DOI][PubMed]
  • 12. Atlas of selected results of the 2011 national population and housing census Statistical center of Iran 2014;
  • 13. Abdolvahab M, Behnaz K, Sima B, M T. Hepatitis a in young adults in the golestan province, northeast of iran. J Glob Infect Dis. 2010; 2(2): 198-9[DOI][PubMed]
  • 14. Sofian M, Aghakhani A, Farazi AA, Banifazl M, Etemadi G, Azad-Armaki S, et al. Seroepidemiology of hepatitis A virus in children of different age groups in Tehran, Iran: implications for health policy. Travel Med Infect Dis. 2010; 8(3): 176-9[DOI][PubMed]
  • 15. Miri R, Ghezeldasht SA, Hedayati-Moghadam MR, Fathimoghadam F, Bidkhori H, Shamsian SA, et al. Seropositivity of antibodies against hepatitis a virus in mashhad, northeast of iran, 2009: A cross-sectional community-based study. Razavi Int J Med. 2015; 3(2)
  • 16. Ghasemian R, Alian S. Age-specific seroprevalence of hepatitis A in SARI (northern part of IRAN). Int J Infect Dis. 2010; 14: 223[DOI]
  • 17. Ataei B, Nokhodian Z, Javadi AA, Kasaeyan N, Farajzadegan Z, Shoaei P, et al. Seroepidemiology of hepatitis a virus infections in over 6-years population in isfahan, iran: A community-based study. Journal of Isfahan Medical School. 2008; 25(86): 46-53
  • 18. Taghavi Ardakani A, Soltani B, Sehat M, Namjoo S, Haji Rezaei M. Seroprevalence of anti-hepatitis a antibody among 1 - 15 year old children in kashan-iran. Hepat Mon. 2013; 13(5): 10553[DOI][PubMed]
  • 19. Noroozi M, Moradi F, Hasanzadeh A, Banazadegan R, Basiri MR, Ramezani A, et al. Seroprevalence of hepatitis a and hepatitis e in qom province, 2011. Iran J Infect Dis Trop Med. 2012; 17(58): 19-23
  • 20. Saffar MJ, Abedian O, Ajami A, Abedian F, Mirabi AM, Khalilian AR, et al. Age-specific seroprevalence of anti-hepatitis a antibody among 1-30 years old population of savadkuh, mazandaran, iran with literature review. Hepat Mon. 2012; 12(5): 326-32[DOI][PubMed]
  • 21. Hosseini Shokouh SJ, Dadashi A, Abiri M, Zohrevand I, Eshraghian A, Khoshdel A, et al. HAV Immunity in Iranian Medical Students. Hepat Mon. 2015; 15(3): 26219[DOI][PubMed]
  • 22. Ceran N, Yuksel Kocdogan F, Mert D, Erdem I, Dede B, Adaleti R, et al. Hepatitis A seroprevalence in children and young adults in Istanbul, Turkey: seroprevalence change and associated factors. J Viral Hepat. 2012; 19(1): 72-6[DOI][PubMed]
  • 23. Erdogan MS, Otkun M, Tatman-Otkun M, Akata F, Ture M. The epidemiology of hepatitis a virus infection in children, in Edirne, Turkey. Eur J Epidemiol. 2004; 19(3): 267-73[PubMed]
  • 24. Halicioglu O, Akman SA, Tatar B, Atesli R, Kose S. Hepatitis A seroprevalence in children and adolescents aged 1-18 years among a low socioeconomic population in Izmir, Turkey. Travel Med Infect Dis. 2012; 10(1): 43-7[DOI][PubMed]
  • 25. Kaya D, Guler E, Ekerbicer HC, Dilber C, Karabiber H, Guler S, et al. Hepatitis A seroprevalence and its relationship with environmental factors in children of different age groups in Kahramanmaras, Eastern Mediterranean region of Turkey. J Viral Hepat. 2007; 14(12): 830-4[DOI][PubMed]
  • 26. Alkhalidi J, Alenezi B, Al-Mufti S, Hussain E, Askar H, Kemmer N, et al. Seroepidemiology of hepatitis A virus in Kuwait. World J Gastroenterol. 2009; 15(1): 102-5[PubMed]
  • 27. Salama I, Samy SM, Shaaban FA, Hassanin AI, Abou Ismail LA. Seroprevalence of hepatitis A among children of different socioeconomic status in Cairo. East Mediterr Health J. 2007; 13(6): 1256-64[PubMed]
  • 28. Hayajneh WA, Balbeesi A, Faouri S. Hepatitis A virus age-specific sero-prevalence and risk factors among Jordanian children. J Med Virol. 2015; 87(4): 569-74[DOI][PubMed]
  • 29. Kotwal A, Singh H, Verma AK, Gupta RM, Jain S, Sinha S, et al. A study of Hepatitis A and E virus seropositivity profile amongst young healthy adults in India. Med J Armed Forces India. 2014; 70(3): 225-9[DOI][PubMed]
  • 30. Pinheiro RS, Araujo LA, Caetano KA, Matos MA, Carneiro MA, Teles SA. Intermediate Endemicity of Hepatitis a Virus Infection in Rural Settlement Projects of Southwest Goias, Brazil. Arq Gastroenterol. 2015; 52(3): 200-3[DOI][PubMed]
  • 31. Duval B, De Serres G, Ochnio J, Scheifele D, Gilca V. Nationwide canadian study of hepatitis a antibody prevalence among children eight to thirteen years old. Pediatr Infect Dis J. 2005; 24(6): 514-9[PubMed]
  • 32. Melhem NM, Talhouk R, Rachidi H, Ramia S. Hepatitis A virus in the Middle East and North Africa region: a new challenge. J Viral Hepat. 2014; 21(9): 605-15[DOI][PubMed]
  • 33. Inter-agency regional response for Syrian refugees health and nutrition bulletin: Iraq, Jordan and Lebanon, January-March 2014 2014;
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader